COX‐2 and cancer: a new approach to an old problem

British Journal of Pharmacology (2001) 134, 1137–1150; doi:10.1038/sj.bjp.0704365

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of pharmacology 2001-11, Vol.134 (6), p.1137-1150
1. Verfasser:	Bakhle, Y S
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiogenesis Animals Anti-Inflammatory Agents, Non-Steroidal - pharmacology APC apoptosis aspirin Aspirin - pharmacology Biological and medical sciences breast cancer carcinogenesis Carcinogenesis, carcinogens and anticarcinogens chemoprevention chemotherapy colorectal Colorectal Neoplasms - drug therapy Colorectal Neoplasms - enzymology Colorectal Neoplasms - etiology Cyclooxygenase 2 cyclo‐oxygenase cytokines Epidemiologic Studies epidemiology FAP Foods and miscellaneous HNPCC Humans Isoenzymes - metabolism lung Medical sciences Membrane Proteins Min mouse NSAID PPAR Prostaglandin-Endoperoxide Synthases - metabolism Prostaglandins - biosynthesis prostate Receptors, Cytoplasmic and Nuclear - drug effects Reviews sulindac thiazolidinedione Transcription Factors - drug effects Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	British Journal of Pharmacology (2001) 134, 1137–1150; doi:10.1038/sj.bjp.0704365
ISSN:	0007-1188 1476-5381
DOI:	10.1038/sj.bjp.0704365